Company Median Diagnostics Inc.

Equities

A233250

KR7233250000

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
11,990 KRW +4.26% Intraday chart for Median Diagnostics Inc. -1.72% -25.02%

Business Summary

Median Diagnostics Inc. is a Korea-based company principally engaged in the manufacture and distribution of veterinary medicines. The Company in control of the technology include hybridoma cell fusion technology, monoclonal antibody bank, recombinant expression, lateral flow technology, stabilization technology and other veterinary medicine technology. The Company distributes its products within domestic market and to overseas markets.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Veterinary Medicine - Manufactured Product
95.6 %
23,528 94.7 % 11,358 95.6 % -51.73%
Veterinary Medicine - Merchandise
4.2 %
1,290 5.2 % 497 4.2 % -61.47%
Other
0.3 %
15 0.1 % 31 0.3 % +107.14%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
68.1 %
19,916 80.2 % 8,094 68.1 % -59.36%
Overseas
31.9 %
4,917 19.8 % 3,792 31.9 % -22.88%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 -
Director of Finance/CFO 49 -
Comptroller/Controller/Auditor 57 -
Sales & Marketing 51 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 64 -
Chief Executive Officer 56 -
Director/Board Member 37 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,746,534 291,670 ( 16.70 %) 99,300 ( 5.686 %) 16.70 %

Company contact information

Median Diagnostics Inc.

878, Sunhwan-daero Dongnae-myeon

24399, Chuncheon-si

+

http://www.mediandiagnostics.com
address Median Diagnostics Inc.(A233250)
  1. Stock Market
  2. Equities
  3. A233250 Stock
  4. Company Median Diagnostics Inc.